Skip to main content
. Author manuscript; available in PMC: 2020 Jul 7.
Published in final edited form as: Anticancer Res. 2019 May;39(5):2277–2287. doi: 10.21873/anticanres.13344

Figure 6.

Figure 6.

Tumor sphere formation and drug sensitivity. A: Representative image of 4T1 tumor sphere (scale bar=100 μm). B: Numbers of primary and secondary 4T1 tumor spheres (n=3). C: Lapatinib reduced 4T1 tumor sphere formation. D: Inhibitor of activin-like kinase 4/5/7 receptor signaling SB-505124 had no effect on 4T1 tumor sphere formation. Data are presented as the mean±standard error. DMSO: Dimethyl sulfoxide; SFE: Sphere-forming efficiency.